Trial Profile
A Phase II, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of the Salfaprodil for Injection in Patients With Acute Ischemic Stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Nelonemdaz (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ENIS
- Sponsors GNT Pharma
- 25 Jul 2020 Status changed from recruiting to completed.
- 22 Mar 2016 New trial record